# mGFR vs tGFR in AKI

> **NCT07632469** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Bin Du** · enrollment: 50 (estimated)

## Conditions studied

- AKI
- GFR

## Interventions

- **DEVICE:** transdermal GFR

## Key facts

- **NCT ID:** NCT07632469
- **Lead sponsor:** Bin Du
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-08
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-05-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07632469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07632469, "mGFR vs tGFR in AKI". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07632469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*